CellBion Co.
Latest round
- Series C
Last raised
- Dec 2017
Total raised
- $12M
Investors
- 8
About CellBion Co.
, operates as a biopharmaceutical company that specializes in the development of radiopharmaceuticals and radioligand therapies that target cancer in patients., Ltd. The company offers radiopharmaceuticals and medical imaging systems associated with lower side effects, attributed to the very short hydrophilic linker that allows quick excretion through the kidneys, reducing side effects. The company uses medical imaging techniques, including mPERCIST and RECIST, to assess the response to treatment.
Who invested in CellBion Co.
8 investors across 5 rounds
See all investors in CellBion Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CellBion Co.
Who invested in CellBion Co.?
CellBion Co. has 8 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CellBion Co. raised?
CellBion Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did CellBion Co. last raise money?
CellBion Co.'s most recent round on record is a Series C, in Dec 2017.
What does CellBion Co. do?
, operates as a biopharmaceutical company that specializes in the development of radiopharmaceuticals and radioligand therapies that target cancer in patients.
Where is CellBion Co. headquartered?
CellBion Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like CellBion Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at CellBion Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like CellBion Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.